Excretion of tacrolimus glucuronides in human bile

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 22, Issue 3, 1997, Pages 217-221

  Firdaous, I ^a   Verbeeck, R K ^b   Hassoun, A ^a   Langrehr, J M ^c   Wallemacq, P E ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c NONE

Author keywords

In vivo glucuronidation; Tacrolimus; Therapeutic drug monitoring; Transplantation

Indexed keywords

BETA GLUCURONIDASE; DRUG METABOLITE; GLUCURONIDE; MONOCLONAL ANTIBODY; SULFATASE; TACROLIMUS;

ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG HYDROLYSIS; DRUG ISOLATION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; PH;

EID: 0030712890     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189810     Document Type: Article

References (14)

1. Venkataramanan R., Jain A., Cadoff E. et al. (1990) : Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant. Proc., 22 (suppl 1), 52-56.
2. Christians U., Kruse C., Kownatzki R. et al. (1991) : Measurement of FK 506 by HPLC and isolation and characterization of its metabolites. Transplant. Proc., 23, 940-941.
3. Shah I.A., Whiting P.H., Omar G., Thomson A.W., Burke M.D. (1991) : Effects of FK 506 on human hepatic microsomal cytochrome P-450-dependent drug metabolism in vitro. Transplant. Proc., 23, 2783-2785.
4. Sattler M., Guengerich F.P., Yun C.H., Christians U., Sewing F.K. (1992) : Cytochrome P-450 3A enzymes are responsible for biotransformation of FK 506 and rapamycin in man and rat. Drug Metab. Dispos., 20, 753-761.
5. Stiff D.D., Venkataramanan R., Tara T.N.V. (1992) : Metabolism of FK 506 in differentially induced rat liver microsomes. Res. Commun. Chem. Pathol., 78, 121-124.
6. Vincent S.H., Karanam B.V., Painter S.K., Chiu S.H.L. (1992) : In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. Arch. Biochem. Biophys., 294, 454-460.
7. Christians U., Braun F., Kosian N. et al. (1991) : High performance liquid chromatography/mass spectrometry of FK 506 and its metabolites in blood, bile and urine of liver grafted patients. Transplant. Proc., 23, 2741-2744.
8. Iwasaki K., Shiraga T., Matsuda H., Nagase K. (1995) : Identification and biological activities of the metabolites oxidised at multiple sites of FK506. Drug Metab. Dispos., 23, 28-34.
9. Lhoëst G., Maton N., Verbeeck R. (1993) : Isolation and identification of a novel isomerized epoxide metabolite of FK-506 from erythromycin-induced rabbit liver microsomes. Drug Metab. Dispos., 21, 850-854.
10. Venkataramanan R., Swaminathan A., Prasad T. et al. (1995) : Clinical pharmacokinetics of tacrolimus. Clin. Pharmacokinet., 29, 404-430.
11. Miners J.O., Lillywhite K.J., Yoovathaworn K., Pongmarutal M., Birkett D.J. (1990) : Characterization of paracetamol UDP-glucuronosyltransferase activity in human liver microsomes. Biochem. Pharmacol., 40, 595-600.
12. George A., Hazelton, Curtis D. Klaassen (1988) : UDP-Glucuronosyltransferase activity toward digitoxigenin-monodigitoxoside. Drug Metab. Dispos., 16, 30-36.
13. Firdaous I., Hassoun A., Otte J.B. et al. (1995) : HPLC-Microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients. Clin. Chem., 41, 1292-1296.
14. Kroemer H.K., Klotz U. (1992) : Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin. Pharmacokinet., 23, 292-310.